Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
C nhiu nm kinh nghim cng tc trong lnh vc Dc phm
Zepbound's December 2024 FDA approval for obstructive sleep apnea (OSA) opens an entirely new patient population, with tirzepatide now the first approved pharmacotherapy for OSA
For patients: prioritize clinicians who explain sourcing, dosing, risks, and long-term strategies
Sources: Neelakantan et al., Biochem Pharmacol 2018 | Dimet-Wiley et al., Sci Rep 2024 Security Profile & Chemical Identity Molecular specifications and preclinical safety data 5-Amino-1MQ Chemical Identity A small molecule derived from quinolinium salts, developed at the University of Texas (2017) 5-Amino-1MQ Tolerance & Status Safety data from preclinical studies (DIO mouse model) Published Preclinical Data 3 key studies published in Biochemical Pharmacology and Scientific Reports 35% Reduction of white adipose tissue in 11 days (20 mg/kg, 3 times/day) Physical Effects (11 days) + 40 % Improvement of grip strength in aged mice (22-24 months) Strength & Performance (aged mice) microbiome The combination of 5-Amino-1MQ + caloric restriction establishes a distinct gut microbial profile Protocol & Results Important Notice Search Only Not intended for human consumption
US$ 27.31
US$ 27.93
US$ 27.98
US$ 29.78
US$ 21.90
US$ 22.22
US$ 24.27
US$ 21.56
US$ 25.31
US$ 28.44